ESR2 and breast cancer: Moreover, silencing beclin1 reduced autophagy and reversed the inhibitory effect of ERβ/CLDN6 on the migration and invasion of breast cancer cells and attenuated the inhibitory effect of CLDN6 on metastasis in vivo.